Beauty Ingredient Tech Boom: biotech inputs reach an ever-expanding cosmetics and personal care market
Vytrus Biotech began as a spin-off of the University of Barcelona, an institution with over 50 years of plant cell culture technology to its credit. In 2011, the company successfully developed and began producing a first ingredient for the cosmetic market.
In 2014, the company went global. And just last week Vytrus Biotech signed a distribution deal with Grupo Blumos to bring its portfolio—of now 10+ cosmetic actives—to beauty makers in Argentina, Paraguay, and Uruguay.
Vytrus Biotech reaches new LATAM markets and 60 countries globally
Commenting on the newly singed deal, Vytrus Biotech Business Manager Daniel Robustillo tells the press, “Argentina is a relevant cosmetic market to consider and is aligned with the profile that Vytrus seeks for the international expansion of its pipeline, in addition to opening potential opportunities for the pharmaceutical market in the future.”
Grupo Blumos will help Vytrus Biotech reach new LATAM markets in the cosmetics industry, and as Robustillo notes, eventually in the pharma market in Argentina, Paraguay, and Uruguay as well.
Grupo Blumos is a privately owned company, in business since 1947, that serves the industries as diverse as tech, mining, industrial chemical, animal nutrition, food, pharma, and nutraceuticals.
This month Vytrus Biotech also signed a deal with Nano Tech Chemical Brothers to distribute the company’s cosmetic actives in India. All told, these new distribution partnerships expand the ingredient maker’s reach to 60 countries—an international presence that amounts to 70% of Vytrus ingredient sales, according to this month’s press release about these latest partnerships.
Remarkable beauty ingredient tech from Vytrus
Vytrus Biotech made headlines here on Cosmetics Design last spring with the launch of DEOBIOME, a microbiome-friendly ingredient made from the stem cells of Morinda citifrolia, commonly known as Noni fruit. As the company explained at the time of DEOBIOME launch, this is “the first deodorant treatment that allows the axilla to perspire while avoiding the bad odor generation [all] while respecting the skin microbiota and the ecosystem.”
Deodorant continues to be an important personal care category for the company and the industry; in fact both Vytrus Biotech Business Manager Daniel Robustillo and Cosmetics Design Editor Deanna Utroske will be speaking as part of the Innovation in Deodorants Webinar (hosted by the National Biofilms Innovation Centre and Cosmetics Cluster UK) on April 27. (Dr Carol Treasure, Founder and CEO of XCellR8 and Dr Simon Jackson, CSO and Co Founder Modern Botany will also speak as part of the event.)
Vytrus Biotech has also gain a fair amount of recognition for its award-winning KANNABIA SENSE, which uses an ingredient derived from plant stem cells of the Cannabis sativa plant. The new ingredient acts on the skin-brain axis, stimulating the skin microbiome to create an oxytocin-like response and affect mood and the self-perception of appearance.